Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.19.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 6,345 $ 5,342
Premium and trade receivables 5,819 5,150
Short-term investments 697 722
Other current assets 755 784
Total current assets 13,616 11,998
Long-term investments 7,186 6,861
Restricted deposits 582 555
Property, software and equipment, net 1,800 1,706
Goodwill 6,981 7,015
Intangible assets, net 2,208 2,239
Other long-term assets 1,196 527
Total assets 33,569 30,901
Current liabilities:    
Medical claims liability 7,381 6,831
Accounts payable and accrued expenses 4,641 4,051
Return of premium payable 718 666
Unearned revenue 363 385
Current portion of long-term debt 40 38
Total current liabilities 13,143 11,971
Long-term debt 6,775 6,648
Other long-term liabilities 2,007 1,259
Total liabilities 21,925 19,878
Commitments and contingencies
Redeemable noncontrolling interests 10 10
Stockholders’ equity:    
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at March 31, 2019 and December 31, 2018 0 0
Common stock, $0.001 par value; authorized 800,000 shares; 419,058 issued and 413,305 outstanding at March 31, 2019, and 417,695 issued and 412,478 outstanding at December 31, 2018 0 0
Additional paid-in capital 7,491 7,449
Accumulated other comprehensive earnings (loss) 38 (56)
Retained earnings 4,185 3,663
Treasury stock, at cost (5,753 and 5,217 shares, respectively) (174) (139)
Total Centene stockholders’ equity 11,540 10,917
Noncontrolling interest 94 96
Total stockholders’ equity 11,634 11,013
Total liabilities, redeemable noncontrolling interests and stockholders’ equity $ 33,569 $ 30,901